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increased from 5 to 55 mM (release stimulation). Radioac- 
tive products used were D,L-norepinephrine 3H-7, 8-20 
Ci/mmole, serotonin 14C-1 40 mCi/mmole, and dopamine 
3H 1-2, 15-20 Ci/mmole (CEA Saclay). 
Results. With concentrations higher than 10 -8 M, SAH 
increased NE and 5HT uptake in the 3 parts of the brain, 
but did not affect DA uptake (figure 1). Increase was 
significant in cortex (32%) and brainstem (17%) for NE and 
in cortex (25%), midbrain (28%) and brainstem (18%) for 
5HT. SAH (10 -6 or 10 -5 M) did not alter DA, NE and 5HT 
release, either spontaneous or induced by KC1. 
Administered in vivo to the animal 1 h prior to sacrifice 
(7 mg/kg i.p.) it induced in vitro uptake increase for NE 
and 5HT, significant only in brainstem and midbrain 
(figure 2), but did not alter DA uptake. 
Discussion. The above results are to be compared with the 
action of 2 drugs acting on the central nervous system: a) 
Diphenylhydantoine, an anticonvulsant product, induces in 
vitro NE uptake increase in the whole brain (NE 10 -6 M) 9, 
but its effect is clear with a concentration 10 times higher 
than concentration of SAH. An increase of NE and 5HT 
uptake, when discharging is generalized, might explain the 
anticonvulsant effect of both drugs, b) Methionine sulfox- 
imine, a convulsant product l~ lowers SAH level in different 
parts of rat brainl]. 
Therefore SAH seems to be involved in the regulation of 
the metabolism of 2 neurotransmitters NE and 5HT. The 
1st point of impact of SAH might be located at the level of 
catechol-O-methyltransferase; it is possible that SAH inhi- 
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bits the formation of uptake-inhibiting methylated prod- 
ucts. This mechanism seems to be rather unlikely, as, in our 
experimental conditions, few methylated products are 
formed, and the main product, normetanephrine, is a very 
weak uptake inhibitor 12. Administration of SAH in vivo 
and observation of the effect in vitro seems to show a 
strong affinity of SAH for NE and 5HT uptake system; 
thus a direct action of SAH on uptake mechanism at the 
membrane level is more credible. 
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Summary. This study suggests that replacement of intracellular potassium by rubidium ions might lower the resting 
membrane potential. Thus rubidium-treated rats were more responsive to depolarizing influences and generated more 
cyclic AMP in the brainstem and consequently the behavioral changes. 
Meltzer and associates 2 reported that rubidium injection 
increased the prevalent frequency of the electroencephalo- 
gram in monkey and altered the behavior in the direction 
of increased activity. They further suggested that rubidium, 
like lithium, might have therapeutic application in the 
affective disorders. Stolk et al. 3 reported that treatment of 
rats for 10 days with rubidium caused an increase in the 
rate of disappearance of norepinephrine in the brainstem 
after the biosynthesis of norepinephrine was inhibited, 
suggesting the antidepressant potential of rubidium. The 
antidepressant properties of rubidium in humans is bein~ 
investigated in the metabolic wards of several countries 4'~. 
Johnson 6 demonstrated that rubidium-treated rats recorded 
an increase in both the vertical rearing and horizontal 
locomotor activity. The objective of this investigation was 
to gain some insights into the mechanism of rubidinm- 
induced hyperactivity in the rat. 
Methods. Male Sprague-Dawley rats with an average b. wt 
of 150 g were purchased from Spartan Research Animals, 
Inc., Haslett, Michigan. Upon arrival, rats were randomly 
paired and housed in stainless steel cages. The animal room 
was illuminated from 08.00 to 20.00 h, and the thermostat 
was set at 25 ~ Rats were allowed a week to acclimate to 
the laboratory environment, and food was available ad 
libitum. Experimental animals were given 50 mM rubidium 
chloride in their drinking water while control rats received 
equimolar sodium chloride solution. Motor activity was  
measured on an activity platform (Lafayette Instrument 
Company) each day at 16.00 h. Only I control and 1 
experimental rat were tested each day. Animals were taken 
to a dark room and acclimated for 30 min in solitude under 
red light. The motor activity for the next 30 min were then 
measured. The sensitivity of the instrument was adjusted so 
that only large body movements of the rat were recorded. 
An electric timer was used to terminate the experiment at 
the end of 30 rain. 
After ingestion of rubidium chloride solution for 4 weeks, 
each rat was acclimated to the microwave oven for 3 
consecutive days to minimize stress prior to sacrifice. At 
14.00 h on the following day, 1 control and 1 experimental 
rat were subjected to microwave irradiation individually, as 
described by Schmidt et al. 7,s. Animals were then decapitat- 
ed and the heads were chilled in ice. The brain was 
Ingestion of 50 mM rubidium chloride in the drinking water for 
1 month on brain potassium concentration* in the rat 
Control Experimental 
Rubidium 0.2 +_ 0.1 32.5 + 1.9 
Potassium 118.8 +_ 4.4 84.4 _+ 3.3 
Rubidium+ potassium 119.0 116.9 
*Values, expressed as meq/kg wet wt, represent the mean_+SE 
of 5-8 animals. 
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separated into brainstem, cerebel lum and forebrain 9. Cyclic 
AMP was assayed per procedure of  G i lman  1~ as modif ied  
by Weller  et al. u. A Perkin-Elmer  atomic absorption spec- 
t rophotometer  (model  403) equipped with a 3-slot nebuliz- 
er burner  was used for the determinat ion o f  rubidium, 
sodium, potassium, calcium and magnesium ions 12. 
Results. Rubidium-trea ted  rats appeared more alert and 
aggressive relative to the sodium-treated controls. Hyperac-  
tivity was observed starting 2 weeks after rubidium inges- 
tion. The activity meter  reading ( m e a n + S E ) f o r  rubidium- 
treated rats was 121+10 cpm as compared to 63+5 cpm for 
controls. Rubid ium ingestion hat no effect on sodium, 
calcium and magnesium concentrations in the brain. 
However,  rubidium was found to replace brain potassium 
approximately on a molar  basis (table). The figure shows 
that ingestion o f  50 m M  rubidium chloride for 1 month  
lead to almost a doubling of  the cyclic A M P  concentration 
in the brainstem. There was also a general but  statistically 
insignificant (p > 0.05) increase of  cyclic A M P  levels in the 
forebrains and cerebellums of  rubidium-treated rats. 
Discussion. The literature report that rubidium treatment  
increased locomotor  activity in the rat 6 was also observed in 
this laboratory. In addition, this study demonstrated the 
replacement  of  brain potassium by rubidium in the rat. 
This may result in a less negative resting membrane  poten- 
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Effect of ingestion of 50 mM rubidium chloride for 1 month on 
cyclic AMP levels in the rat; * p < 0.05. 
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to depolarizing influences. It is therefore reasonable to 
predict that rubidium-treated rats may have a higher neur-  
onal firing rate, which in turn releases more catecholamines 
at the nerve ending. This can explain the findings of  Stolk 
et al. 3 that greater amount  o f  neuronal  stored norepineph-  
fine were released to central adrenergic receptors in the rat 
after rubidium injections. 
Cyclic A M P  has been established to be the intracellular 
messenger mediat ing the biological effects of  norepineph-  
fine 14. Increased levels of  cyclic A M P  would result in the 
activation of  phosphorylase kinase in the synaptic region 
and phosphorylat ion of  proteins in the plasma m e m -  
brane 15'16. Altered membrane  permeabil i ty may then facili- 
tate synaptic transmission 17, which could be expressed as 
hyperactivity in the affected animal.  
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Summary. The protective efficacy of  an orally administered bovine protein-free parathyroid extract (PF-PTE)  was studied 
on rat bone marrow cells in vivo with the mitotic index after 850 R irradiation. A remarkable decrease was found in the 
mitotic activity of  bone marrow cells after irradiation in the non-protected animals. However,  in the animals treated with 
PF-PTE after irradiation, a significantly smaller  decrease and a faster recovery were found in the mitotic activity of  the 
bone marrow cells. 
We have demonstrated recently I that a bovine protein-free 
parathyroid extract (PF-PTE) increased the survival of  
850 R and 1000 R whole-body X-ray irradiated rats. It was 
assumed that the radioprotective effect of  the protein-free,  
and consequently calcium-inactive extract, was mainly due 
to a hitherto unknown water-soluble bioactive agent. The  
aim of  this study was to investigate the mode  of  action of  
this agent. The preparat ion of  PF-PTE was described 
previously 2. The experiment  was carried out in male C F E  
rats weighing 150-250 g. The whole-body irradiations were 
exposed by a Super Liliput 200 X-ray apparatus (Medicor,  
Budapest) 180 kV, 4 mA, filtered with 0.5 m m  Cu, the 
focus-target distance: 50 cm, with a dose-rate o f  7.8 R per  
min. The mitotic activity o f  bone marrow was studied after 
850 R whole-body irradiation. 1 group of  the irradiated 
animals ( n =  30) received 0.1 ml physiological saline i.p. as 
the solvent of  PF-PTE,  on the day of  X-ray exposure and 
on the 3 successive days thereafter. Another  group of  
